Pfizer Inc., the world’s leading healthcare company,
is driven by its dedication to the discovery and development
of innovative medicines, and to making these available
to patients all over the world. It has achieved breakthroughs
in the treatment of a wide range of serious diseases that
have long afflicted mankind, including heart disease,
hypertension, cancer, bacterial and fungal infections,
depression and erectile dysfunction. All
these medical breakthroughs that have made people healthier
and live longer with better quality of life have been
largely due to the substantial resources Pfizer has
devoted to research and development.
Pfizer
has been steadily increasing its investments in research
and development over the past decades. Last year alone,
Pfizer spent more than $7.1 billion for R & D. In
fact, it is now considered the world’s largest
privately-funded biomedical research organization, with
research projects spanning 18 therapeutic areas- more
than that of any other company.
Pfizer’s
research and development covers virtually every aspect
of pharmaceutical research, including that in the emerging
field of genomics. The company maintains 8 major R&D
facilities around the world, with over 12,500 scientists
hard at work producing safe, effective and innovative
medicines.
Pfizer
has also formed partnerships with numerous pharmaceutical
companies, universities, and other government and non-government
organizations in order to further strengthen the company’s
commitment to looking for new ways to treat diseases.
"Since
Pfizer came to the Philippines in 1954, we have been
making available to Filipinos the new medicines that
have been the result of our global R&D efforts.
Those medicines have helped make Filipinos live healthier
and the quality of their lives better,” said Gerry
Bacarro Pfizer’s president & country manager.
“As
we celebrate our 50th anniversary in the Philippines
this year, we renew our commitment to bringing those
life-saving medicines to our countrymen just as fast
as they are developed by our researchers and scientists
and approved for use by health authorities,” he
further stated.
“Among
the medical treatments available, pharmaceuticals still
offer the least intrusive and most cost-effective means
to battle diseases. Filipinos can depend on research-based
pharmaceutical companies like Pfizer to continue of
its efforts in finding and perfecting medicines that
will help lessen treatment costs, control symptoms and
alleviate pain,” Bacarro added.
|
